- Home
- AM vs LNTH Comparison
AM vs LNTH Comparison
Compare AM & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AM | LNTH |
|---|---|---|
| Founded | 2013 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 4.2B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AM | LNTH |
|---|---|---|
| Price | $18.03 | $63.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $18.83 | ★ $74.17 |
| AVG Volume (30 Days) | ★ 2.4M | 1.0M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.98% | N/A |
| EPS Growth | ★ 20.98 | N/A |
| EPS | 0.98 | ★ 2.39 |
| Revenue | $1,249,571,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $4.60 | $0.01 |
| Revenue Next Year | $3.01 | $1.24 |
| P/E Ratio | ★ $18.43 | $26.37 |
| Revenue Growth | ★ 8.70 | 1.95 |
| 52 Week Low | $14.22 | $47.25 |
| 52 Week High | $19.82 | $111.29 |
Technical Indicators
Market Signals| Indicator | AM | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 65.58 |
| Support Level | $18.21 | $60.15 |
| Resistance Level | $18.88 | $64.40 |
| Average True Range (ATR) | 0.37 | 2.16 |
| MACD | 0.05 | 0.45 |
| Stochastic Oscillator | 39.65 | 86.21 |
Price Performance
Historical ComparisonAbout AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.